Abstract
With the tetracycline (Tc)-controlled gene expression system (Tet system), an experimental approach has been developed that permits alteration of individual gene activities in complex genetic systems in a truly conditional fashion, i.e., it is temporally defined, quantitative, and reversible. Monitoring the phenotypic changes that accompany such highly defined alterations has provided new insights into numerous biologic processes hereto not amenable to genetic dissection. The various versions of the Tet system (1–3) were successfully incorporated into a variety of model organisms such as Streptomyces cerevisiae, Dictyostelium, Drosophila, Arabidopsis, moss, mice, and rats (for review, see refs. 3–5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gossen M. and Bujard H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547–5551.
Gossen M., Freundlieb S., Bender G., et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 26, 1766–1769.
Baron U. and Bujard H. (2000) The Tet-repressor based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol. 327, 401–421.
Gossen M. and Bujard H. (2001) Tetracyclines in the control of gene expression in eukaryotes. In: Tetracyclines as Molecular Probes for Micro and Mammalian BiologyNelson M., Hillen W., and Greenwald R.A. (eds.), Birkhäuser Verlag, Basel.
Mansuy I. M. and Bujard H. (2000) Tetracycline-regulated gene expression in the brain. Curr. Opin. Neurobiol. 10, 593–596.
Shin M. K., Levorse J. M., Ingram R. S., and Tilghman S. M. (1999) The temporal requirement for endothelin receptor-B signaling during neural crest development. Nature. 402, 496–501.
Yamamoto A., Lucas J., and Hen R. (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell. 101, 57–66.
Tremblay P., Meiner Z., Galou M., et al. (1998) Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc. Natl. Acad. Sci. USA 95, 12580–12585.
Felsher D. W. and Bishop J. M. (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199–207.
Chin L., Tam A., Pomerantz J., et al. (1999) Essential role for oncogenic Ras in tumor maintenance. Nature 400, 468–472.
Xie W., Chow L. T., Paterson A. J., Chin E., and Kudlow J. E. (1999) Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFa expression in transgenic mice. Oncogene 18, 3593–3607.
Mayford M., Bach M. E., Huang Y., et al. (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274, 1678–1683.
Malleret G., Haditsch U., Genoux D., et al. (2001) Inducible and reversible enhancement of learning, memory and longterm potentiation by genetic inhibition of calcineurin. Cell 104, 675–686.
Freundlieb S., Baron U., Bonin A.L., Gossen M., and Bujard H. (1997) Use of tetracycline controlled gene expression systems to study mammalian cell cycle. Methods Enzymol. 283, 159–173.
Freundlieb S., Baron U., and Bujard H. (1998) Controlling gene activities via the tetracycline regulatory systems. In: Celis J., ed. Cell Biology: A Laboratory Handbook, 2nd ed., vol. 4, Academic Press, San Diego, CA, pp.230–238.
Kistner A., Gossen M., Zimmermann F., et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10933–10938.
Hillen W. and Berens C. (1994) Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48, 345–369.
Hlavka J. J. and Bothe J. H. (1985) The Tetracyclines. Handbook of Experimental Pharmacology, vol. 78, Springer-Verlag, Berlin.
Mansuy I. M., Winder D. G., Moallem T. M., et al. (1998) Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 21, 257–265.
Ray P., Tang W., Wang P., et al. (1997) Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and-independent phenotypes. J. Clin. Invest. 100, 2501–2511.
Urlinger S., Baron U., Thellmann M., et al. (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 97, 7963–7968.
Baron U., Gossen M., and Bujard H. (1997) Tetracycline controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 25, 2723–2729.
Baron U., Freundlieb S., Gossen M., and Bujard H. (1995) Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res. 23, 3605–3606.
Hasan M. T., Schoenig K., Berger S., Graewe W., and Bujard H. (2001) Longterm, non-invasive imaging of regulated gene expression in living mice. Genesis 29, 116–122.
Fishman G. I., Kaplan M. L., and Buttrick P. M. (1994) Tetracycline regulated cardiac gene expression in vivo. J. Clin. Invest. 93, 1864–1868.
Lee P., Morley G., Huang Q., et al. (1998) Conditional lineage ablation to model human diseases. Proc. Natl. Acad. Sci. USA 95, 11371–11376.
Kistner A. (1996) Ph.D. Thesis. University of Heidelberg, Heidelberg, Germany.
Lamartina S., Rinaudo D., Roseilli G., et al. (2001) Stringent control of gene expression in vivo using novel doxycycline dependent transactivators. Hum. Gene Ther. 13, 199–210.
Corti O., Sabaté O., Horellou P., et al. (1999) A single adenovirus vector mediates doxycycline controlled expression of tyrosine hydroxylase in brain gafts of human neural progenitors. Nat. Biotechnol. 17, 349–354.
Bohl D., Naffakh N., and Heard J. M. (1997) Longterm control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat. Med. 3, 299–305.
Bond C. T., Sprengel R., Bissonnette J. M., et al. (2000) Respiration and parturition affected by conditional overexpression of the Ca2+-activated K+ channel subunit, SK3. Science 289, 1942–1946.
Gill G. and Ptashne M. (1988) Negative effect of the transcriptional activator GAL4. Nature 334, 721–724.
Efrat S., Fusco-DeMane D., Lemberg H., al Emran O., and Wang X. (1995) Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline regulated oncogene. Proc. Natl. Acad. Sci. USA 92, 3576–3580.
Legname G., Seddon B., Lovatt M., et al. (2000) Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. Immunity 12, 537–546.
Scott K., Brady R. Jr., Cravchik A., et al. (2001) A chemosensory gene family encoding candidate gustatory and olfactory receptors in Drosophila. Cell 104, 661–673.
Talbot D., Descombes P., and Schibler U. (1994) The 5′ flanking region of the rat LAP C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. Nucleic Acids Res. 22, 756–766.
Perea J., Robertson A., Tolmachova T., et al. (2001) Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum. Mol. Genet. 10, 1007–1018.
Krestel H. E., Mayford M., Seeburg P. H., and Sprengel R. (2001) A GFPequipped bidirectional expression module well suited for monitoring tetracyclineregulated gene expression in mouse. Nucleic Acids Res. 29, E39.
Schönig K., Schwenk F., Rajewsky K., and Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo-te LC-1 mouse line (submitted).
Freundlieb S., Schirra-Müller C., and Bujard H. (1999) A tetracycline controlled activation/repression system for mammalian cells. J. Gene Med. 1, 4–12.
Zhu H., Ma B., Homer R. J., Zheng T., and Elias J.A. (2001) Use of the tetracycline controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J. Biol. Chem. 276, 25222–25229.
Clement J. Q., Qian L., Kaplinsky N., and Wilkinson M. F. (1999) The stability and fate of a spliced intron from vertebrate cells. RNA 5, 206–220.
Contag P. R., Olomu I. N., Stevenson D. K., and Contag C. H. (1998) Bioluminescent indicators in living mammals. Nat. Med. 4, 245–247.
Utomo A. R., Nikitin A.Y., and Lee W. H. (1999) Temporal, spatial and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat. Biotechnol. 17, 1091–1096.
Passman R. S. and Fishman G. I. (1994) Regulated expression of foreign genes in vivo after germline transfer. J. Clin. Invest. 94, 2421–2425.
Hennighausen L., Wall R. J., Tillmann U., Li M., and Furth P. A. (1995) Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J. Cell. Biochem. 59, 463–472.
Manickan E., Satoi J., Wang T. C., and Liang T. J. (2001) Conditional liverspecific expression of simian virus 40 T antigen leads to regulatable development of hepatic neoplasm in transgenic mice. J. Biol. Chem. 276, 13989–13994.
Chen J., Kelz M. B., Zeng G., et al. (1998) Transgenic animals with inducible, targeted gene expression in brain. Mol. Pharmacol. 54, 495–503.
Sarao R. and Dumont D. J. (1998) Conditional transgene expression in endothelial cells. Transgenic Res. 7, 421–427.
Guo Y., Zhao J., Sawicki J., Peralta Soler A., and O’Brien T. G. (1999) Conversion of C57Bl/6 mice from a tumor promotion-resistant to a-sensitive phenotype by enhanced ornithine decarboxylase expression Mol. Carcinog. 26, 32–36.
Diamond I., Owolabi T., Marco M., Lam C., and Glick A. (2000) Conditional gene expression in the epidermis of transgenic mice using the tetracyclineregulated transactivators tTA and rtTA linked to the keratin 5 promoter. J. Invest. Dermatol. 115, 788–794.
Leenders H., Whitfield S., Benoist C., and Mathis D. (2000) Role of the forkhead transcription family member, FKHR, in thymocyte differentiation. Eur. J. Immunol. 30, 2980–2990.
Witherden D., van Oers N., Waltzinger C., et al. (2000). Tetracyclinecontrollable selection of CD4(+) T cells. Half-life and survival signals in the absence of major histocompatibility complex class II molecules. J. Exp. Med. 191, 355–364.
Ahmad A., Brinson M., Hodges B. L., Chamberlain J. S., and Amalfitano A. (2000) Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy. Hum. Mol. Gen. 9, 2507–2515.
Nikitin A.Y., Shan B., Flesken-Nikitin A., Chang K. H., and Lee W. H. (2001) The retinoblastoma gene regulates somatic growth during mouse development. Cancer Res. 61, 3110–3118.
Hess J., Nielsen P. J., Fischer K.-D., Bujard H., and Wirth T. (2001) The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol. Cell. Biol. 21, 1531–1539.
Saam J. R. and Gordon J. I. (1999) Inducible gene knock outs in the small intestine and colonic epithelium. J. Biol. Chem. 274, 38071–38082.
Chang M. A., Horner J. W., Conklin B., et al. (2000) Tetracycline-inducible system for photoreceptor-specific gene expression. Invest. Ophthalmol. Vis. Sci. 41, 4281–4287.
Tichelaar J. W., Lu W., and Whitsett J. A. (2000) Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J. Biol. Chem. 275, 11858–16649.
Ye L., Chan S., Chow Y. H., Tsui L. C., and Hu J. (2001) Regulated expression of the human cftr gene in epithelial cells. Mol. Ther. 3, 723–733.
Ju H., Gros R., You X., et al. (2001) Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc. Natl. Acad. Sci. USA 98, 7469–7474.
Krestel H. E., Mayford M., Seeburg P. H., and Sprengel R. (2001) An GFPequipped bidirectional expression module well suited for monitoring tetracyclineregulated gene expression in mouse. Nucleic Acids Res. 29
Mansuy I. M., Mayford M., Jacob B., Kandel E. R., and Bach M. E. (1998) Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 92, 39–49.
Jerecic J., Single F., Kruth U., et al. (1999) Studies on conditional gene expression in the brain. Ann. NY Acad. Sci. 868, 27–37.
Huettner C. S., Zhang P., Van Etten R. A., and Tenen D. G. (2000) Reversibility of acute B-cell leukaemia induced by BCR-ABL-1. Nat. Gen. 24, 57–60.
Bowman J. C., Steinberg S. F., Jiang T., et al. (1997) Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J. Clin. Invest. 100, 2189–2195.
Redfern C. H., Coward P., Degtyarev M. Y., et al. (1999) Conditional expression and signaling of a specifically designed G(i)-coupled receptor in transgenic mice. Nat. Biotechnol. 17, 165–169.
Kelz M. B., Chen J., Carlezon W. A., Jr., et al. (1999) Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 16, 272–276.
Clark J. C., Tichelaar J. W., Wert S. E., et al. (2001) FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L705–715.
Lucas J. J., Hernandez F., Gomez-Ramos P., et al. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 27–39.
Soulier S., Stinnakre M. G, Lepourry L., Mercier J.-C., and Vilotte J.-L (1999) Use of doxycycline-controlled gene expression to reversibly alter milk-protein composition in transgenic mice. Eur. J. Biochem. 260, 533–539.
Pan Z. Z., Parkyn L., Ray A., and Ray P. (2000) Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, 658–666.
Neuhold L. A., Killar L., Zhao W., et al. (2001) Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107, 35–44.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Schönig, K., Bujard, H. (2003). Generating Conditional Mouse Mutants via Tetracycline-Controlled Gene Expression. In: Hofker, M.H., van Deursen, J. (eds) Transgenic Mouse. Methods in Molecular Biology™, vol 209. Humana Press. https://doi.org/10.1385/1-59259-340-2:69
Download citation
DOI: https://doi.org/10.1385/1-59259-340-2:69
Publisher Name: Humana Press
Print ISBN: 978-0-89603-915-5
Online ISBN: 978-1-59259-340-8
eBook Packages: Springer Protocols